An angiotensin-converting enzyme (ACE) inhibitor or an angiotensin II receptor blocker (ARB) should be used at the earliest sign of albuminuria (albumin - to - creatinine ratio ≥ 30 mg / g), to prevent progression of renal disease because these drugs lower intraglomerular blood pressure and thus have renoprotective effects.